Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-02-05 | ImmunoGen, Inc. | Coen Stacy Ann
(SVP & CHIEF BUSINESS OFFICER) |
S | Common Stock | D | 4583 | $29.30 - $29.30 | $134,281 |
| 2024-02-02 | ImmunoGen, Inc. | Coen Stacy Ann
(SVP & CHIEF BUSINESS OFFICER) |
M | Common Stock | A | 14350 | $0.00 - $0.00 | $0 |
| 2024-02-05 | ImmunoGen, Inc. | Wingrove Theresa
(SVP OF REGULATORY AFFAIRS) |
S | Common Stock | D | 12027 | $29.30 - $29.30 | $352,391 |
| 2024-02-02 | ImmunoGen, Inc. | Wingrove Theresa
(SVP OF REGULATORY AFFAIRS) |
M | Common Stock | A | 29640 | $0.00 - $0.00 | $0 |
| 2024-02-05 | ImmunoGen, Inc. | Enyedy Mark J
(CHIEF EXECUTIVE OFFICER) |
S | Common Stock | D | 20107 | $29.28 - $29.28 | $588,732 |
| 2024-02-02 | ImmunoGen, Inc. | Enyedy Mark J
(CHIEF EXECUTIVE OFFICER) |
M | Common Stock | A | 51234 | $0.00 - $0.00 | $0 |
| 2024-02-05 | ImmunoGen, Inc. | Lentini Renee
(VP & PRIN ACCTG OFFICER) |
S | Common Stock | D | 2631 | $29.30 - $29.30 | $77,088 |
| 2024-02-02 | ImmunoGen, Inc. | Lentini Renee
(VP & PRIN ACCTG OFFICER) |
M | Common Stock | A | 8435 | $0.00 - $0.00 | $0 |
| 2024-01-16 | ImmunoGen, Inc. | Wingrove Theresa
(SVP OF REGULATORY AFFAIRS) |
S | Common Stock | D | 187667 | $29.64 - $29.64 | $5,562,449 |
| 2024-01-16 | ImmunoGen, Inc. | Wingrove Theresa
(SVP OF REGULATORY AFFAIRS) |
M | Common Stock | A | 187667 | $4.83 - $5.75 | $961,847 |
| 2023-12-29 | ImmunoGen, Inc. | Coen Stacy Ann
(SVP & CHIEF BUSINESS OFFICER) |
M | Common Stock | A | 30000 | $5.32 - $5.32 | $159,600 |
| 2023-12-29 | ImmunoGen, Inc. | Wingrove Theresa
(SVP OF REGULATORY AFFAIRS) |
A | Common Stock | A | 615 | $16.01 - $16.01 | $9,846 |
| 2023-12-15 | ImmunoGen, Inc. | Wingrove Theresa
(SVP OF REGULATORY AFFAIRS) |
S | Common Stock | D | 117445 | $29.40 - $29.40 | $3,452,883 |
| 2023-12-15 | ImmunoGen, Inc. | Wingrove Theresa
(SVP OF REGULATORY AFFAIRS) |
M | Common Stock | A | 117445 | $4.55 - $5.32 | $603,410 |
| 2023-11-29 | ImmunoGen, Inc. | Wingrove Theresa
(SVP OF REGULATORY AFFAIRS) |
S | Common Stock | D | 171216 | $16.66 - $28.95 | $4,873,228 |
| 2023-11-29 | ImmunoGen, Inc. | Wingrove Theresa
(SVP OF REGULATORY AFFAIRS) |
M | Common Stock | A | 171216 | $10.65 - $10.79 | $1,827,752 |
| 2023-11-15 | ImmunoGen, Inc. | Wingrove Theresa
(SVP OF REGULATORY AFFAIRS) |
S | Common Stock | D | 166725 | $15.85 - $15.85 | $2,642,591 |
| 2023-11-15 | ImmunoGen, Inc. | Wingrove Theresa
(SVP OF REGULATORY AFFAIRS) |
M | Common Stock | A | 166725 | $4.55 - $4.55 | $758,598 |
| 2023-11-15 | ImmunoGen, Inc. | Coen Stacy Ann
(SVP & CHIEF BUSINESS OFFICER) |
S | Common Stock | D | 108609 | $16.01 - $16.05 | $1,741,958 |
| 2023-11-15 | ImmunoGen, Inc. | Coen Stacy Ann
(SVP & CHIEF BUSINESS OFFICER) |
M | Common Stock | A | 108609 | $4.92 - $7.69 | $762,113 |
| 2023-11-07 | ImmunoGen, Inc. | Wingrove Theresa
(SVP OF REGULATORY AFFAIRS) |
S | Common Stock | D | 19517 | $16.66 - $16.66 | $325,153 |
| 2023-11-07 | ImmunoGen, Inc. | Wingrove Theresa
(SVP OF REGULATORY AFFAIRS) |
M | Common Stock | A | 19517 | $10.65 - $10.65 | $207,856 |
| 2023-11-06 | ImmunoGen, Inc. | Lentini Renee
(VP & PRIN ACCTG OFFICER) |
S | Common Stock | D | 219545 | $15.29 - $15.29 | $3,356,843 |
| 2023-11-06 | ImmunoGen, Inc. | Lentini Renee
(VP & PRIN ACCTG OFFICER) |
M | Common Stock | A | 120528 | $2.68 - $10.79 | $943,438 |
| 2023-11-07 | ImmunoGen, Inc. | Wallace Richard John
(Director) |
M | Common Stock | A | 10000 | $14.70 - $14.70 | $147,000 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |